|
GPR173 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.0705999999986E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53290000000284E-05 |
| Normal-vs-Stage2 |
5.572000E-01 |
| Normal-vs-Stage3 |
9.274000E-02 |
| Normal-vs-Stage4 |
1.325440E-01 |
| Stage1-vs-Stage2 |
3.881800E-02 |
| Stage1-vs-Stage3 |
1.125540E-02 |
| Stage1-vs-Stage4 |
1.185640E-01 |
| Stage2-vs-Stage3 |
6.994600E-01 |
| Stage2-vs-Stage4 |
5.440600E-01 |
| Stage3-vs-Stage4 |
6.946600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.66539999999893E-05 |
| Normal-vs-AfricanAmerican |
1.254400E-01 |
| Normal-vs-Asian |
4.000000E-02 |
| Caucasian-vs-AfricanAmerican |
6.445400E-01 |
| Caucasian-vs-Asian |
7.875600E-01 |
| AfricanAmerican-vs-Asian |
5.796000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.557600E-03 |
| Normal-vs-Female |
2.771600E-04 |
| Male-vs-Female |
6.052600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.415510E-04 |
| Normal-vs-Age(41-60Yrs) |
3.495900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.980400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.870800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.287000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.000100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.593800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.291970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.261400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.956400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.696900E-03 |
| Classical-VS-Follicular |
1.417150E-04 |
| Classical-VS-Other |
4.850800E-01 |
| Classical-VS-Normal |
2.05199999991912E-07 |
| Tall-VS-Follicular |
2.461800E-01 |
| Tall-VS-Other |
3.640200E-01 |
| Tall-VS-Normal |
3.292200E-01 |
| Follicular-VS-Other |
3.131400E-01 |
| Follicular-VS-Normal |
5.809600E-01 |
| Other-VS-Normal |
3.322200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.118000E-02 |
| Normal-vs-N1 |
7.441900E-03 |
| N0-vs-N1 |
4.079600E-01 |
|
|
